Abstract:Background and Purpose: Probenecid (PROB) has been used for decades to treat gouty arthritis with few side effects and recent studies revealed that it is also a specific inhibitor of pannexin-1 channel. Panx1 channel was activated by ischemic injury and inhibition of the panx1 channel maybe efficacious in stroke treatment. However, the role of PROB in cerebral ischemia /reperfusion (I/R) injury remains unclear. The aim of this study was to investigate the role of PROB in the transient global cerebral I/R injury in rats and its protective mechanisms. Methods: Twenty minutes of transient global cerebral I/R was induced using the four-vessel occlusion (4-VO) method in rats. PROB was given in the different dose, time and administration routes to verify its neuroprotective effects. Neuronal death in the hippocampal CA1 region was observed using H & E staining 7 days after ischemia. Molecular mechanisms of activation of calpain-cathepsin pathway and inflammatory cells by I/R injury were also investigated. Results: Treatment with PROB (0.1, 1 and 10 mg/kg ) 10 min before ischemia protected against I/R-induced hippocampal CA1 neuronal death significantly, and 1 mg/kg has best protective effect. Post-insult treatment 2h after reperfusion also protected against neuronal death and prolonged use for continuous 7 days could improve its protective effects compared to the single use 6h after reperfusion.Furthermore,oral administration also had protective effect. Cathepsin B expression was inceased significantly in CA-1 region after ischemia and PROB treatment could inhibit its expression. Expression of both calpain-1 and hsp70 at 1d ,2d and 3d after reperfusion were upregulated, whereas the expression of calpain-1 was inhibited and hsp70 was strengthened by pre-treatment with PROB. Prolonged PROB treatment suppressed the activation of microglia and astrocytes, reduced the number of microglia in CA1 region. Conclusions: Our study indicates that PROB protects against transient global cerebral I/R injury administrated before ischemia and even 6h after reperfusion by reducing calpain-1 expression , inhibiting lysosomal rupture and the activation of the glia, which suggests RPOB may be a promising therapeutic drug for clinical treatment of ischemic cerebral injury.

Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration

Exogenous progesterone:a potential candidate of neuroprotective drug

Inhibitory Effect of Progesterone on Inflammatory Factors after Experimental Traumatic Brain Injury.

Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion.

Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion

Progesterone Alleviates Acute Brain Injury Via Reducing Apoptosis and Oxidative Stress in A Rat Experimental Subarachnoid Hemorrhage Model

Progesterone Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Rats

Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection

Progestogen-mediated neuroprotection in central nervous system disorders

Improved Outcomes from the Administration of Progesterone for Patients with Acute Severe Traumatic Brain Injury: a Randomized Controlled Trial.

Progesterone Improves Neurobehavioral Outcome in Models of Intracerebral Hemorrhage

Progesterone induces neuroprotection associated with immune/inflammatory modulation in experimental traumatic brain injury

A role of endogenous progesterone in stroke cerebroprotection revealed by the neural-specific deletion of its intracellular receptors.

Progress of progesterone usage in traumatic brain injury

Anti-Inflammatory Effects of Progesterone in Lipopolysaccharide-Stimulated BV-2 Microglia

Efficacy of Progesterone for Acute Traumatic Brain Injury: a Meta-analysis of Randomized Controlled Trials

Effect of Progesterone Administration on the Prognosis of Patients with Severe Traumatic Brain Injury: a Meta-Analysis of Randomized Clinical Trials.

Abstract W P257: Progesterone Improves Long-term Neurobehavioral Outcome in Models of Intracerebral Hemorrhage (ICH)

Therapeutic potential of progesterone in spinal cord injury‐induced neuropathic pain: at the crossroads between neuroinflammation and N‐methyl‐D‐aspartate receptor

Protective Effects of Progesterone on Early Brain Injury in Rats after Subarachnoid Hemorrhage

Cerebroprotection by progesterone following ischemic stroke: multiple effects and role of the neural progesterone receptors.